The authors aim to provide a clinically-focused summary of psychiatric complications of inflammatory bowel disease (IBD), and give treatment recommendations.
A narrative review of literature drawn from PubMed and Medline.
Conclusions:
IBD is a chronic, debilitating and potentially body integrity altering condition with significant morbidity and a slight increase in mortality. Co-morbidity with anxiety and depression is common. Onset in the younger years can disturb development. Psychotherapy may be most useful for addressing fatigue, pain and assisting with coping. There is a lack of evidence to guide treatment of depression in this population.
LoftusEVJr.Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence and environmental influences. Gastroenterology2004; 126: 1504–1517.
2.
HalpinSJFordAC. Prevalence of symptoms meeting criteria for irritable bowel syndrome in inflammatory bowel disease: Systematic review and meta-analysis. Am J Gastroenterol2012; 107: 1474–1482.
3.
Jelsness-JorgensenLPBernklevTMoumB. Coexisting irritable bowel-like symptoms in inflammatory bowel disease in remission is associated with impaired social functioning and increased bodily pain. GastroenterolNurs2014; 37: 280–287.
4.
FriedmanSBlumbergRS. Chapter 295. Inflammatory Bowel Disease. In: LongoDLFauciASKasperDL. (eds) Harrison’s Principles of Internal Medicine, 18e. New York, NY: The McGraw-Hill Companies, 2012.
5.
SelingerCPAndrewsJMTitmanA. Long-term follow-up reveals low incidence of colorectal cancer, but frequent need for resection, among Australian patients with inflammatory bowel disease. Clin Gastroenterol Hepatol2014; 12: 644–650.
6.
JohnstonRDLoganRF. What is the peak age for onset of IBD?Inflamm Bowel Dis2008; 14: S4–5.
7.
StjernmanHTyskCAlmerS. Worries and concerns in a large unselected cohort of patients with Crohn’s disease. Scandinav J Gastroenterol2010; 45: 696–706.
8.
LongMDBarnesELHerfarthHH. Narcotic use for inflammatory bowel disease and risk factors during hospitalization. InflammBowel Dis2012; 18: 869–876.
9.
AndrewsJMMountifieldREVan LangenbergDR. Un-promoted issues in inflammatory bowel disease: Opportunities to optimize care. Internal Med J 2010; 40: 173–182.
10.
WalkerJREdigerJPGraffLA. The Manitoba IBD cohort study: A population-based study of the prevalence of lifetime and 12-month anxiety and mood disorders. Am J Gastroenterol2008; 103: 1989–1997.
11.
WalkerEAGelfandANGelfandMD. Psychiatric diagnoses, sexual and physical victimization, and disability in patients with irritable bowel syndrome or inflammatory bowel disease. Psycholog Med1995; 25: 1259–1267.
12.
GraffLAWalkerJRBernsteinCN. Depression and anxiety in inflammatory bowel disease: A review of comorbidity and management. Inflamm Bowel Dis2009; 15: 1105–1118.
13.
MittermaierCDejacoCWaldhoerT. Impact of depressive mood on relapse in patients with inflammatory bowel disease: A prospective 18-month follow-up study. Psychosomat Med2004; 66: 79–84.
14.
TimmerAPreissJCMotschallE. Psychological interventions for treatment of inflammatory bowel disease. Cochrane Datab Systemat Rev2011: CD006913.
15.
VogelaarLVan’t SpijkerATimmanR. Fatigue management in patients with IBD: A randomised controlled trial. Gut2014; 63: 911–918.
16.
VogelaarLVan’t SpijkerAVogelaarT. Solution focused therapy: A promising new tool in the management of fatigue in Crohn’s disease patients’ psychological interventions for the management of fatigue in Crohn’s disease. J Crohn Colitis2011; 5: 585–591.
17.
Garcia-VegaEFernandez-RodriguezC. A stress management programme for Crohn’s disease. Behav Res Ther2004; 42: 367–383.
18.
DeterHCKellerWvon WietersheimJ. Psychological treatment may reduce the need for healthcare in patients with Crohn’s disease. Inflamm Bowel Dis2007; 13: 745–752.
19.
ElsenbruchSLanghorstJPopkirowaK. Effects of mind-body therapy on quality of life, and neuroendocrine and cellular immune functions, in patients with ulcerative colitis. Psychother Psychosomat2005; 74: 277–287.
20.
MaunderRGEsplenMJ. Supportive-expressive group psychotherapy for persons with inflammatory bowel disease. Canadian J Psychiatry Revue Canadienne Psychiatrie2001; 46: 622–626.
21.
WilliamsSDaleJ. The effectiveness of treatment for depression/depressive symptoms in adults with cancer: A systematic review. Brit J Cancer2006; 94: 372–390.
22.
Mikocka-WalusAATurnbullDAMouldingNT. Antidepressants and inflammatory bowel disease: A systematic review. Clin Pract EpidemiolMental Health2006; 2: 24.
23.
GoodhandJRGreigFIKoodunY. Do antidepressants influence the disease course in inflammatory bowel disease? A retrospective case-matched observational study. Inflamm Bowel Dis2012; 18: 1232–1239.
